Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Patricia Severns
Ibrutinib Discontinuation in Waldenström Macroglobulinemia: Etiologies, Outcomes, and IgM Rebound
American Journal of Hematology
Hematology
Related publications
PATIENT-REPORTED OUTCOMES (PROs) IN WALDENSTRÖM MACROGLOBULINEMIA (WM) PATIENTS TREATED WITH IBRUTINIB-RITUXIMAB IN THE INNOVATE STUDY
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Waldenström Macroglobulinemia
Spotting the Elusive Siberian Tiger: Complete Response to Ibrutinib in a Patient With Waldenström Macroglobulinemia
American Journal of Hematology
Hematology
A Head-To-Head Phase 3 Study Comparing BGB-3111 and Ibrutinib in Patients With Waldenström Macroglobulinemia
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Bone Marrow Microenvironment in Waldenström Macroglobulinemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Waldenström Macroglobulinemia: Review of Pathogenesis and Management
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Predictors of Symptomatic Hyperviscosity in Waldenström Macroglobulinemia
American Journal of Hematology
Hematology
CNS Vasculitis Associated With Waldenström Macroglobulinemia
Case Reports in Neurological Medicine
A 50-Year-Long Study of Waldenström Macroglobulinemia
Mayo Clinic Proceedings
Medicine